Klinge Corporation
Cold Chain Refrigerated and Freezer ISO Container Systems
The U Food and Drug Administration (FDA) has completed its review of Moderna’s investigational new drug (IND) application for Covid-19 vaccine candidate, mRNA-1273, authorising the company to conduct a Phase II study.
The protocol for Phase III study of mRNA-1273 has also been finalised. While the Phase II clinical trial is set to begin soon, the Phase III study will be conducted later this year.
Cold Chain Refrigerated and Freezer ISO Container Systems
Passive Thermal Protection and Cargo Security Solutions for the Global Supply Chain
Flexible Powder Containment Technologies